FDA approves Ortho Evra’s new warning label
Johnson & Johnson, the makers of the Ortho Evra (norelgestromin/ethinyl estradiol) birth control patch, has updated the drug’s warning label to include new data on the odds ratio estimates of venous thromboembolism risk in women on Ortho Evra compared to users of oral contraceptives. The new label was approved by the Food and Drug Administration (FDA).
![[ Beasley Allen Law Firm Logo ]](http://www.orthoevra-legal.com/wp-content/themes/system-unity/images/logo.png)
Alisha Gutcher was just 24 years old when she suffered from chest pains and lightheadedness. “My heart was just freaking out,” she said to the
Leslie Niedner can’t make sense of the death of her 17-year-old daughter Adrianna. She was a healthy and active college freshman. It was later revealed that what killed her was a blood clot in her lung, also known as a pulmonary embolism. But how could such a condition happen to someone so young and healthy?
A patch-delivery system is now available to consumers who want or need more of the vitamin B-12, an essential vitamin that plays a key role in the normal functioning of the brain and nervous system and for the formation of blood. B-12 is naturally found in meat, shellfish, milk, eggs and fortified cereals, but many people’s digestive systems do not absorb enough B-12, which can lead to vitamin B-12 deficiency. A B-12 deficiency can contribute to anemia, which can leave you feeling weak, lightheaded, depressed and tired.
More than 40 drug development programs have transdermal systems, or drug patches, under development for either initial approval or expanded indications, according to
A British survey suggests one in three women spend no more than five minutes selecting a suitable contraceptive method to use, according to